Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methylidene-octahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol Acetic Acid Salt
2. 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol
3. Aqx-1125
1. 782487-28-9
2. Aqx-1125
3. Aqx-1125 Free Base
4. Rosiptor [usan]
5. (1s,3s,4r)-4-[(3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methylidene-3,3a,4,5,6,7-hexahydro-2h-inden-5-yl]-3-(hydroxymethyl)-4-methylcyclohexan-1-ol
6. 6r5034f862
7. Unii-6r5034f862
8. Rosiptor (usan/inn)
9. Rosiptor [inn]
10. Rosiptor [who-dd]
11. Gtpl9249
12. Chembl3989954
13. Schembl16055992
14. Aqx1125
15. Aqx 1125
16. Aqx-1125aqx-1125
17. Db13012
18. Ac-30923
19. Hy-109011
20. Cs-0030509
21. D11275
22. A902928
23. Q27074488
24. 7-amino-17-methylidene-6,7-seco-5.alpha.-androstane-3.beta.,6-diol
25. (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1- Methyleneoctahydro -1h - Inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
26. (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
27. Cyclohexanemethanol, 2-((3as,4r,5s,7as)-4-(aminomethyl)octahydro-7a-methyl-1-methylene-1h-inden-5-yl)-5-hydroxy-2-methyl-, (1s,2r,5s)-
28. Rosiptor; Aqx-1125; Aqx 1125; Aqx1125;(1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol
Molecular Weight | 321.5 g/mol |
---|---|
Molecular Formula | C20H35NO2 |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 321.266779359 g/mol |
Monoisotopic Mass | 321.266779359 g/mol |
Topological Polar Surface Area | 66.5 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 465 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
71
PharmaCompass offers a list of AQX-1125 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AQX-1125 manufacturer or AQX-1125 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AQX-1125 manufacturer or AQX-1125 supplier.
PharmaCompass also assists you with knowing the AQX-1125 API Price utilized in the formulation of products. AQX-1125 API Price is not always fixed or binding as the AQX-1125 Price is obtained through a variety of data sources. The AQX-1125 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AQX 1125 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AQX 1125, including repackagers and relabelers. The FDA regulates AQX 1125 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AQX 1125 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AQX 1125 supplier is an individual or a company that provides AQX 1125 active pharmaceutical ingredient (API) or AQX 1125 finished formulations upon request. The AQX 1125 suppliers may include AQX 1125 API manufacturers, exporters, distributors and traders.
AQX 1125 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AQX 1125 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AQX 1125 GMP manufacturer or AQX 1125 GMP API supplier for your needs.
A AQX 1125 CoA (Certificate of Analysis) is a formal document that attests to AQX 1125's compliance with AQX 1125 specifications and serves as a tool for batch-level quality control.
AQX 1125 CoA mostly includes findings from lab analyses of a specific batch. For each AQX 1125 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AQX 1125 may be tested according to a variety of international standards, such as European Pharmacopoeia (AQX 1125 EP), AQX 1125 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AQX 1125 USP).